Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence.
Pouliou, Evi; Xochelli, Aliki; Kanellis, George; Stalika, Evangelia; Sutton, Lesley-Ann; Navarro, Alba; Agathangelidis, Andreas; Dimosthenous, Kypros; Anagnostopoulos, Achilles; Patsouris, Efstratios; Korkolopoulou, Penelope; Sundstrom, Christer; Ghia, Paolo; Ponzoni, Maurilio; Sander, Birgitta; Campo, Elias; Rosenquist, Richard; Hadzidimitriou, Anastasia; Stamatopoulos, Kostas; Papadaki, Theodora.
Am J Pathol
; 187(7): 1454-1458, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28457696
Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
New paradigms in mantle cell lymphoma: is it time to risk-stratify treatment based on the proliferative signature?
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
Characteristics of human primary mantle cell lymphoma engraftment in NSG mice.
Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia.
Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markers.
Molecular evidence for antigen drive in the natural history of mantle cell lymphoma.
A lowered 26S proteasome activity correlates with mantle lymphoma cell lines resistance to genotoxic stress.
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.